Protocol Number; CAIN457L1401

JRCT ID: jRCT2031210589

Registered date:31/01/2022

Basic Information

• Recruitment status: Not Recruiting
• Health condition(s) or Problem(s) studied: psoriasis vulgaris,psoriatic arthritis,pustular psoriasis
• Date of first enrollment: 28/02/2022
• Target sample size: 35
• Study type: Observational

Outcome(s)

• Primary Outcome: Incidence of serious adverse events(52weeks)

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: < 18age old
• Gender: Both

Include criteria

1.Patients who have obtained written consent from their legally acceptable representative to cooperate in this survey before the start of treatment with this drug
2.Patients aged less than 18 years at the start of treatment with this drug
3.Patients newly treated with this drug for any of the following diseases: Psoriasis vulgaris, psoriatic arthritis, pustular psoriasis

Exclude criteria

1.Prior treatment with this drug
2.Participation in an interventional study (e.g., a clinical trial) at the time of starting this drug.

Related Information

• Primary Sponsor: Toshiya Sugimoto